Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Janz, Martin Dr. (7) Kammertöns, Thomas Dr. (2) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lusatis, Simone (1) Mathas, Stephan Dr. (10) Pezzutto, Antonio Prof. Dr. (2) Selbach, Matthias Prof. Dr. (6) Uckert, Wolfgang Prof. Dr. (4) Willimsky, Gerald Dr. (5) (-) Blankenstein, Thomas Prof. Dr. (19) (-) Daniel, Peter Prof. Dr. (1) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (3) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (19) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) (-) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (4) (-) 2007 (5) 2008 (5) 2009 (2) (-) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (4) 2015 (5) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 22 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 1996200620072010 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Januar 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin 01. Januar 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier 01. Januar 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman 01. Januar 1996 / Gene Ther Cancer vaccines in gene therapy T. Blankenstein Z. Qin 01. Januar 1996 / Hum Gene Ther Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant S. Cayeux C. Beck B. Doerken T. Blankenstein 01. Januar 1996 / Curr Top Microbiol Immunol The influence of local cytokines on tumor metastasis: using cytokine gene transfected tumor cells as experimental models Z. Qin T. Blankenstein 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Januar 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin
01. Januar 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier
01. Januar 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman
01. Januar 1996 / Hum Gene Ther Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant S. Cayeux C. Beck B. Doerken T. Blankenstein
01. Januar 1996 / Curr Top Microbiol Immunol The influence of local cytokines on tumor metastasis: using cytokine gene transfected tumor cells as experimental models Z. Qin T. Blankenstein
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert